Rchr
J-GLOBAL ID：201401074050987886   Update date: Nov. 16, 2024

RAI SHNYA

ライ シンヤ | RAI SHNYA
Affiliation and department：
Kindai University Faculty of Medicine, Department of Medicine

About Kindai University Faculty of Medicine, Department of Medicine


Research field  (1)： Hematology and oncology
Research theme for competitive and other funds  (4)：
  • 2020 - 2023 多発性骨髄腫の病態形成に関わる抗腫瘍免疫機構の解析研究
  • 2018 - 2021 Characterization molecular and immunologic features of CML stem cells for treatment-free remission.
  • 2016 - 2019 Analysis of novel pathogenesis caused by disorder of immature hematopoietic cells in multiple myeloma
  • 2016 - 2017 腫瘍根絶に向けた受容体チロシンキナーゼの細胞内輸送制御による新規抗腫瘍療法の確立
Papers (97)：
  • Koji Izutsu, Kiyoshi Ando, Momoko Nishikori, Hirohiko Shibayama, Hideki Goto, Junya Kuroda, Koji Kato, Yoshitaka Imaizumi, Kisato Nosaka, Rika Sakai, et al. Tazemetostat for relapsed/refractory B-cell non-Hodgkin lymphoma with EZH2 mutation in Japan: 3-year follow-up for a phase II study. International journal of hematology. 2024
  • Shigeru Kusumoto, Wataru Munakata, Ryunosuke Machida, Takashi Terauchi, Hiroaki Onaya, Masahiko Oguchi, Shinsuke Iida, Kisato Nosaka, Yasuhiro Suzuki, Yasuhiko Harada, et al. Interim PET-guided ABVD or ABVD/escalated BEACOPP for newly diagnosed advanced-stage classic Hodgkin lymphoma (JCOG1305). Cancer science. 2024
  • Shinya Rai, Won Seog Kim, Kiyoshi Ando, Ilseung Choi, Koji Izutsu, Norifumi Tsukamoto, Dai Maruyama, Kunihiro Tsukasaki, Junya Kuroda, Jun Ando, et al. Long-term efficacy and safety of tucidinostat in patients with relapsed or refractory peripheral T-cell lymphoma: final analysis of phase IIb results. Haematologica. 2024
  • Jehan Dupuis, Emmanuel Bachy, Franck Morschhauser, Guillaume Cartron, Noriko Fukuhara, Nicolas Daguindau, René-Olivier Casasnovas, Sylvia Snauwaert, Remy Gressin, Christopher P Fox, et al. Oral azacitidine compared with standard therapy in patients with relapsed or refractory follicular helper T-cell lymphoma (ORACLE): an open-label randomised, phase 3 study. The Lancet. Haematology. 2024. 11. 6. e406-e414
  • Koji Kato, Koji Izutsu, Momoko Nishikori, Hirohiko Shibayama, Yoshinobu Maeda, Kenichi Yoshimura, Ukihide Tateishi, Toshihiro Miyamoto, Yasufumi Matsuda, Jun Ishikawa, et al. End-of-treatment 18[F]-FDG PET can predict early progression in patients receiving bendamustine-rituximab for follicular lymphoma in first relapse: a prospective West Japan hematology Study Group (W-JHS) NHL01 trial. International journal of hematology. 2024. 119. 6. 677-685
ｍore...
MISC (18)：
  • 井上宏昭, 頼晋也. Pembrolizumab as a salvage therapy for patients with refractory or relapse primary mediastinal large B-cell lymphoma. 月刊血液内科. 2020. 81. 2
  • 岩田 吉生, 森田 泰慶, 辻 潔, 頼 晋也, 田崎 貴之, 井上 宏昭, 谷口 康博, 藤本 昂, 田中 宏和, 芦田 隆司, et al. 脳静脈洞血栓症を合併し、開頭減圧術・術後エクリズマブ投与が有効であったPNHの一例(Post-operative treatment with eculizumab for PNH presenting as cerebral venous sinus thrombosis). 臨床血液. 2018. 59. 9. 1765-1765
  • 芦田隆司, 芦田隆司, 斎藤花往里, 藤本昴, 末田早苗, 角谷宏明, 大山泰世, 井上宏昭, 谷口康博, 頼晋也, et al. FLU+MELは強度減弱移植前処置として適切でない~D-indexを用いた解析~. 日本造血細胞移植学会総会プログラム・抄録集. 2017. 39th
  • 齋藤 花往里, 頼 晋也, 岩田 吉生, 田中 宏和, 辰巳 陽一, 芦田 隆司, 松村 到, 柳原 緑, 大磯 直毅, 川田 暁. 孤発性皮膚myeloid sarcomaの1例. 臨床血液. 2016. 57. 2. 197-198
  • 藤本昂, 頼晋也, 岩田吉生, 平瀬主税, 森田泰慶, 田中宏和, 辰巳陽一, 芦田隆司, 松村到. CLLの経過中に発症したHodgkin variant of Richter syndromeの1例. 臨床血液. 2016. 57. 2
ｍore...
Patents (1)：
Books (14)：
  • Polatuzumab vedotin in previously untreated DLBCL: an Asia subpopulation analysis from the phase III POLARIX trial.
    2024
  • Epigenetic alterations and advancement of treatment in malignant lymphoma
    2023
  • The role of radiation therapy in the treatment of early-stage Hodgkin lymphoma.
    2021
  • Manntle-cell lymphoma
    2021
  • Mantle cell lymphoma.
    2021
ｍore...
Lectures and oral presentations  (83)：
  • Six cases of oral solid tumor after allogeneic hematopoietic stem cell transplantation
    (日本造血細胞移植学会総会プログラム・抄録集 2021)
  • Gilteritinib treatment for extramedullary relapse of FLT3-ITD acute myeloid leukemia
    (日本造血細胞移植学会総会プログラム・抄録集 2021)
  • Clinical usefulness of Letermovir for patients with stem cell transplantation
    (日本造血細胞移植学会総会プログラム・抄録集 2021)
  • CMML様の病型移行を来したMDSに対してアザシチジンが有効であった1例
    (臨床血液 2021)
  • Outcomes of allo-SCT for patients in non-remission especially with chemoresistance
    (日本造血細胞移植学会総会プログラム・抄録集 2020)
ｍore...
Education (1)：
  • - 2005 Kindai University Faculty of Medicine
Professional career (1)：
  • 医学博士 (近畿大学)
Work history (1)：
  • Kindai University Faculty of Medicine
Association Membership(s) (8)：
日本リンパ網内系学会 ,  THE JAPAN SOCIETY FOR TRANSPLANTATION ,  JAPAN COLLEGE OF RHEUMATOLOGY ,  THE JAPAN SOCIETY OF TRANSFUSION MEDICINE AND CELL THERAPY ,  THE JAPANESE SOCIETY FOR AIDS RESEARCH ,  日本造血細胞移植学会 ,  THE JAPANESE SOCIETY OF HEMATOLOGY ,  THE JAPANESE SOCIETY OF INTERNAL MEDICINE
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM